PTC THERAPEUTICS, INC. — Director's Dealing 2020

Jan 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2020-01-02

Reporting Person: Utter Christine Marie (SVP, Finance & CAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-02	Common Stock	M	2362	$11.23	Acquired	7946	Direct
2020-01-02	Common Stock	S	2362	$47.888	Disposed	5584	Direct
2020-01-03	Common Stock	M	788	$11.23	Acquired	6372	Direct
2020-01-03	Common Stock	S	788	$47.42	Disposed	5584	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-02	Stock Option (Right To Buy)	$11.23	M	2362	Disposed	2027-01-02	Common Stock (2362.0)	Direct
2020-01-03	Stock Option (Right To Buy)	$11.23	M	788	Disposed	2027-01-02	Common Stock (788.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right To Buy)	$490.8	2021-04-27	Common Stock (74.0)	74	Direct
Stock Option (Right To Buy)	$218.4	2022-01-10	Common Stock (21.0)	21	Direct
Stock Option (Right To Buy)	$40.45	2024-09-23	Common Stock (4688.0)	4688	Direct
Stock Option (Right To Buy)	$51.0	2025-01-02	Common Stock (17800.0)	17800	Direct
Stock Option (Right To Buy)	$30.86	2026-01-03	Common Stock (10310.0)	10310	Direct
Stock Option (Right To Buy)	$13.1	2027-06-02	Common Stock (6250.0)	6250	Direct
Stock Option (Right To Buy)	$18.01	2028-01-02	Common Stock (30000.0)	30000	Direct
Stock Option (Right To Buy)	$33.02	2029-01-21	Common Stock (42500.0)	42500	Direct
Stock Option (Right To Buy)	$33.02	2029-01-21	Common Stock (10100.0)	10100	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019.

F2: Includes 371 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2019 and 276 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2019.

F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.55 to $48.46 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F4: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.

F5: Currently exercisable.

F6: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.

F7: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.

F8: This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.